Impact of point‐of‐care HIV viral load and targeted drug resistance mutation testing on viral suppression among Kenyan pregnant and postpartum women: results from a prospective cohort study (Opt4Mamas)

Rena C. Patel; Patrick Oyaro; Katherine K. Thomas; Garoma Wakjira Basha; James Wagude; Irene Mukui; Evelyn Brown; Shukri A. Hassan; Eunice Kinywa; Fredrick Oluoch; Francesca Odhiambo; Boaz Oyaro; Leonard Kingwara; Enericah Karauki; Nashon Yongo; Lindah Otieno; Grace John‐Stewart; Lisa Abuogi

doi:10.1002/jia2.26182

Abstract

This is the authors' abstract. We don't add key points for this paper.

Our combined strategy markedly decreased turnaround time but did not increase VS rates, which were already very high, or sustained VS among pregnant and postpartum women living with HIV. Further research on how best to utilize POC VL and DRM testing is needed to optimize sustained VS among this population.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Patel et al. (2023) studied this question.

synapsesocial.com/papers/69d73289aa68b335b4f30732 https://doi.org/10.1002/jia2.26182

View Full Paper

Ask AI

Bookmark

Share

Impact of point‐of‐care HIV viral load and targeted drug resistance mutation testing on viral suppression among Kenyan pregnant and postpartum women: results from a prospective cohort study (Opt4Mamas)

Abstract

Discussion

Cite This Study

Impact of point‐of‐care HIV viral load and targeted drug resistance mutation testing on viral suppression among Kenyan pregnant and postpartum women: results from a prospective cohort study (Opt4Mamas)

Abstract

Discussion

Cite This Study

Keep reading

Keep reading